Marketable Securities	12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Note 7. Marketable Securities Investments in marketable securities consist of equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification 321 (“ASC 321”). Valuations for marketable securities are based on quoted prices for identical assets in active markets. Where marketable securities were found not be part of an actively traded market, we made a measurement alternative election and estimate the fair value at cost of the investment minus impairment. In December 2021 we sold 3,309,758 shares of common stock of Odyssey Group International, Inc. (“Odyssey”) ticker: ODYY, OTC Markets in a private transaction for a purchase price of $860,491, with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491 (see Note 10), reflecting the market price at that time. The Company recorded an unrealized gain of $203,540 on these marketable securities for the year ended December 31, 2021. The Company owns 826,376,882 shares of common stock of Scepter Holdings, Inc. (“Scepter”), ticker: BRZL, OTC Markets., for a diluted 17% equity holding in the company. In August 2021 we converted $81,768 of our note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted in a $87,044 gain on the disposition of the note receivable. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded which resulted in the Company recording an unrealized loss on marketable securities of $578,464 and $1,297,594 for the years ended December 31, 2022 and 2021. The Company’s previous Chief Executive Officer, who resigned on October 6, 2022, had an immediate family member who sits on the board of directors of Scepter Holdings, Inc. As of December 31, 2022 and 2021 our marketable securities were valued at $1,652,754 and $2,231,218. As of December 31, 2022 and 2021, marketable securities were $1,652,754 and $2,231,218. For the years ended December 31, 2022 and 2021, the Company recorded a total net unrealized loss of $578,464 and $1,094,054 on marketable securities in the statement of operations.

Marketable Securities

12 Months Ended

Dec. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Note 7. Marketable Securities

Investments in marketable securities consist of equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification 321 (“ASC 321”). Valuations for marketable securities are based on quoted prices for identical assets in active markets. Where marketable securities were found not be part of an actively traded market, we made a measurement alternative election and estimate the fair value at cost of the investment minus impairment.

In December 2021 we sold 3,309,758 shares of common stock of Odyssey Group International, Inc. (“Odyssey”) ticker: ODYY, OTC Markets in a private transaction for a purchase price of $860,491, with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491 (see Note 10), reflecting the market price at that time. The Company recorded an unrealized gain of $203,540 on these marketable securities for the year ended December 31, 2021.

The Company owns 826,376,882 shares of common stock of Scepter Holdings, Inc. (“Scepter”), ticker: BRZL, OTC Markets., for a diluted 17% equity holding in the company. In August 2021 we converted $81,768 of our note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted in a $87,044 gain on the disposition of the note receivable. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded which resulted in the Company recording an unrealized loss on marketable securities of $578,464 and $1,297,594 for the years ended December 31, 2022 and 2021. The Company’s previous Chief Executive Officer, who resigned on October 6, 2022, had an immediate family member who sits on the board of directors of Scepter Holdings, Inc. As of December 31, 2022 and 2021 our marketable securities were valued at $1,652,754 and $2,231,218.

As of December 31, 2022 and 2021, marketable securities were $1,652,754 and $2,231,218. For the years ended December 31, 2022 and 2021, the Company recorded a total net unrealized loss of $578,464 and $1,094,054 on marketable securities in the statement of operations.